logo
Salmonella outbreak tied to pistachio cream: See where people got sick

Salmonella outbreak tied to pistachio cream: See where people got sick

USA Today4 hours ago

Salmonella outbreak tied to pistachio cream: See where people got sick
Show Caption
Hide Caption
Tips to help manage food recalls and prevent foodborne illnesses
About 128,000 are hospitalized and 3,000 people die each year from preventable foodborne illnesses.
Payton, USA TODAY
Tubs of pistachio cream are being recalled after nearly half a dozen people reported becoming ill with salmonella infections, according to the Food and Drug Administration (FDA).
Emek-brand Pistachio Cream — a product sold online for wholesale distributors, restaurants, and food service locations across the country — has been linked to a salmonella outbreak in at least two states, the FDA said.
The product, a nut butter spread used in desserts, including ice cream, is manufactured by Emek Dogal Saglik Urunleri Iklim Gida Insaat San Tic Ltd Sti in Turkey and imported into the United States.
The FDA and the Centers for Disease Control and Prevention (CDC), in collaboration with state and local partners, are investigating the multistate outbreak.
As of May 19, four people, three of them in one north central state, reported becoming ill after eating the affected product, the FDA wrote in its updated June 13 post. The FDA said it is also working to determine whether "other lots or products from this firm may be impacted."
Here's what to know about the cream recall:
Tomato recall: Vegetable sold in 3 states now labeled deadly by FDA
What states were people sickened by recalled pistachio cream?
So far, people in two states have reported being sickened from the product, according to the FDA and the CDA.
Minnesota (three people)
New Jersey (one person)
What pistachio cream is being recalled?
The FDA is recalling some Emek-brand Pistachio Cream packaged in a 5-kilogram white tub.
The recalled cream has a use-by date of Oct. 9, 2026, and the production code (PNO:) of 241019.
How many were sickened from recalled pistachio cream?
According to its online post, the FDA was notified by the Minnesota Department of Health about "a cluster of Salmonella illnesses and two Salmonella positive samples of Emek-brand Pistachio Cream product that matched clinical cases by whole genome sequencing (WGS) in this outbreak."
As of June 13, four cases of salmonella infection had been reported from two states. Of those cases, all four reported eating pistachio cream, the FDA said, and three of the four cases reported eating pistachio cream at the same restaurant.
One of the individuals who consumed the affected cream had to be hospitalized, the FDA said.
What is salmonella?
Salmonella is an organism that can cause serious and fatal infections in children, the elderly and others with weakened immune systems, according to the CDC.
Most people infected with salmonella start developing symptoms 12 to 72 hours after eating the contaminated product. Diarrhea, fever and abdominal cramps are the main symptoms.
Most people recover without treatment, but in rare circumstances, the infection can require hospitalization, according to the CDC. Pregnant women are also at higher risk of developing an infection from it and should seek medical attention if symptoms arise.
Consumers experiencing an illness because of the affected product should contact their health care provider to report their symptoms and for medical care.
Natalie Neysa Alund is a senior reporter for USA TODAY. Reach her at nalund@usatoday.com and follow her on X @nataliealund.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Materna Medical Announces Ellora™ and Additional Close on $20M Series B2
Materna Medical Announces Ellora™ and Additional Close on $20M Series B2

Yahoo

time25 minutes ago

  • Yahoo

Materna Medical Announces Ellora™ and Additional Close on $20M Series B2

MOUNTAIN VIEW, Calif., June 17, 2025--(BUSINESS WIRE)--Materna Medical, Inc., a leading innovator in women's pelvic health solutions, has announced the completion of a recent close within an ongoing $20 million Series B2 financing round. The round welcomed new funds GLIN Impact Capital, Wealthing VC Club, and Citrine Angels, and was led by InnovaHealth Partners and other key existing investors Wavemaker Three-Sixty Health, Kimera Limited, Women's Venture Capital Fund, and Golden Seeds. "As we celebrate the addition of these new funds to our investment team, we are also excited to announce the new commercial name for our second product, Ellora™ (formerly Materna Prep), aiming to transform the standard of care in labor and delivery," commented Tracy MacNeal, Chief Executive Officer for Materna Medical "Over 20 of the top hospitals in the US have been incredible partners in the EASE trial for Ellora™, which will be the basis of our FDA De Novo submission this summer." For more information on Materna Medical, visit About Materna Medical Materna Medical is a novel OBGYN platform company defining a $25B market with core technologies addressing unmet needs in women's pelvic health. With headquarters in Mountain View, California, Materna pulls from the top minds in MedTech to truly transform the standard of care in OBGYN. With a diverse team of engineers, scientists, researchers, and commercial leaders, Materna Medical's mission is to empower women to protect their pelvic health. Our first product, Milli™, is vaginal dilator to support patients suffering from vaginismus and related painful sex. In 2019, the Milli device launched as a wellness trainer and, in 2023, received FDA clearance to sell over the counter, enabling streamlined access to people suffering from vaginismus. Milli outcomes have been studied in a post-market prospective virtual study named POMPOM. Materna's second product, Ellora™, is an investigational device used during labor and is intended to reduce pelvic floor muscle injury during vaginal delivery. This product is being studied in the EASE trial, a large, randomized controlled trial in 20 top US hospitals. Materna aims to transform the standard of care in labor and delivery by protecting pelvic floor health for moms. View source version on Contacts Debbie DonovanHead of Commercial OperationsMaterna Medical, Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Dental Care of Stamford announces Breakthrough Bite-Based Treatment During Migraine Awareness Month
Dental Care of Stamford announces Breakthrough Bite-Based Treatment During Migraine Awareness Month

Yahoo

timean hour ago

  • Yahoo

Dental Care of Stamford announces Breakthrough Bite-Based Treatment During Migraine Awareness Month

STAMFORD, CT, June 17, 2025 (GLOBE NEWSWIRE) -- As Migraine Awareness Month shines a spotlight on one of the most debilitating chronic conditions in the world, Dr. Jerry Simon, a leading dental expert in craniofacial pain and neuromuscular dentistry, is offering a fresh perspective on how migraines could be a dental issue hiding in plain sight?Migraines affect more than 35 million Americans annually, often derailing daily life with searing pain, nausea, and visual disturbances. Despite modern medicine's advancements, many patients still struggle to find a sustainable solution, leaving them stuck in a cycle of temporary relief and recurring agony. Dr. Simon believes the answer for many could be closer than they think , right inside their mouth. 'Too many people suffer unnecessarily because the true cause of their pain is being overlooked,' says Dr. Simon. 'What if the root of your migraines isn't neurological, but dental?' The Dental Link to Migraines: An Overlooked Connection Dr. Simon, founder of Dental Care of Stamford and innovator of the FDA-approved Best-Bite Discluder™, is challenging conventional approaches by investigating a common yet often missed culprit: bite imbalances. According to his research and clinical practice, nearly 75% of chronic migraines, neck aches, facial discomfort, and tension headaches stem from misaligned bites also known as malocclusion. This overlooked factor causes the muscles in the jaw and face to overcompensate, leading to inflammation and persistent pain. 'You use your mouth all day—to chew, talk, breathe, even clench unconsciously. If your teeth don't come together properly, your jaw muscles are constantly adjusting, and over time, that stress adds up,' Dr. Simon explains. Quick, Non-Invasive Diagnostic Tool Offers New Path to Relief To pinpoint whether migraines are bite-related, Dr. Simon developed a diagnostic device known as the Best-Bite Discluder™, which helps determine within minutes if a patient's bite is contributing to their head pain. The small, comfortable appliance temporarily disengages the back teeth to relieve pressure. If patients experience immediate relief, even if momentary, it signals that the bite may be the root cause. 'The most powerful moment is watching someone realize that their pain doesn't have to be permanent,' says Dr. Simon. 'If the discluder test helps, it gives us a clear path forward.' Real Stories, Real Relief Former patient S.W., once plagued by chronic migraines and disappointed by countless specialist visits and inconclusive scans, found hope with Dr. Simon. 'I had migraines forever. Undergone endless tests from multiple doctors with no answers. Dr. Simon suggested my teeth could be the issue & then tested my bite. After a few visits, I was already feeling great! He gave me my life back, pain-free!' A Collaborative, Personalized Approach If a bite issue is confirmed, Dr. Simon and his team at Dental Care of Stamford create a customized treatment plan tailored to each patient's unique physiology. This plan may involve bite adjustments, physical therapy, and advanced dental procedures aimed at achieving harmony between the jaw and surrounding muscles - offering lasting relief without reliance on medications or invasive treatments. Raising Awareness, Changing Lives During Migraine Awareness Month, Dr. Simon hopes to educate the public about this little-known yet significant link between dental health and migraines. His goal is to help people who feel like they've exhausted every option and are still searching for answers. 'Migraines are not something people should have to just live with,' says Dr. Simon. 'By identifying and treating the actual source of pain—instead of just masking symptoms - we can truly transform lives.' Schedule Your Consultation Today If you or a loved one has struggled with chronic headaches or migraines, there's no need to wait any longer. Relief could be a simple consultation away. Call (203) 324-6171 or visit CONTACT: Media Contact: Dental Care of Stamford Phone: (203) 324-6171 Email: FrontDesk@ in to access your portfolio

FDA to offer faster drug reviews to companies promoting 'national priorities'

timean hour ago

FDA to offer faster drug reviews to companies promoting 'national priorities'

WASHINGTON -- U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as promoting 'the health interests of Americans,' under a new initiative announced Tuesday. Food and Drug Administration Commissioner Marty Makary said the agency will aim to review select drugs in one to two months. FDA's long-standing accelerated approval program generally issues decisions in six months for drugs that treat life-threatening diseases. Regular drug reviews take about 10 months. Since arriving at the FDA in April, Makary has repeatedly told FDA staff they need to 'challenge assumptions' and rethink procedures. In a medical journal commentary published last week, Makary suggested the agency could conduct 'rapid or instant reviews," pointing to the truncated process used to authorize the first COVID-19 vaccines under Operation Warp Speed. For the new program, the FDA will issue a limited number of 'national priority vouchers' to companies 'aligned with U.S. national priorities,' the agency said in a statement. The special designation will give the selected companies access to extra FDA communications, streamlined staff reviews and the ability to submit much of their product information in advance. Speeding up drug approvals has long been a priority of the pharmaceutical industry, which has successfully lobbied Congress to create a variety of special programs and pathways for faster reviews. Many aspects of the plan announced Tuesday overlap with older programs. But the broad criteria for receiving a voucher will give FDA officials unprecedented discretion in deciding which companies can benefit from the fastest reviews. "The ultimate goal is to bring more cures and meaningful treatments to the American public,' Makary said in a statement. Makary previously said the FDA should be willing to ease its scientific requirements for certain drugs, for instance, by not always requiring randomized studies in which patients are tracked over time to track safety and effectiveness. Such trials are generally considered the gold standard of medical research, though the FDA has increasingly been willing to accept smaller, less-definitive studies for rare or life-threatening diseases. In several recent cases, the FDA has faced criticism for approving drugs based on preliminary data that didn't ultimately show benefits for patients. The push to rapidly accelerated drug approvals is the opposite approach that Makary and his boss, Health Secretary Robert F. Kennedy Jr., have taken on vaccines. Promising a 'return to gold-standard science,' Kennedy previously announced that all new vaccines would have to be compared to placebo, or a dummy shot, to win approval. Kennedy and Makary also have announced a stricter policy on seasonal updates to COVID-19 shots, saying they will have to undergo new testing before they can be approved for use in healthy children and most adults. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store